Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13286 publications
Retinal Detachment in the Setting of Neurofibromatosis Type 1.
Journal: Journal of vitreoretinal diseases
Published: October 20, 2025
Pediatric Renovascular Hypertension: Diagnosis and Management.
Journal: Seminars in interventional radiology
Published: October 13, 2025
Resistant hypertension due to renal artery stenosis in neurofibromatosis type 1: successful management with stenting.
Journal: The Journal of invasive cardiology
Published: October 10, 2025
Evaluation of Ocular Findings in Pediatric Patients With Neurofibromatosis Type 1.
Journal: Journal of child neurology
Published: October 10, 2025
Malignant Melanoma Associated with Neurofibromatosis Type 1.
Journal: Internal medicine (Tokyo, Japan)
Published: October 01, 2025
T1w/T2w ratio suggests reduced intracortical myelin content in youth with RASopathies.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.
Journal: Molecular & cellular oncology
Published: September 26, 2025
Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
Journal: Skin therapy letter
Published: September 24, 2025
Single staged transorbital neuroendoscopic (TONES) approach of managing pulsatile proptosis using patient specific implant (PSI) in orbitopalpebral neurofibromatosis.
Journal: Orbit (Amsterdam, Netherlands)
Published: September 22, 2025
Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas.
Journal: Expert opinion on investigational drugs
Published: September 11, 2025
Last Updated: 10/31/2025